It was only a momentary diversion, but yesterday the Indiana Senate debated a proposed amendment to the offensive bill requiring (among other things) that poor women wanting prescriptions for abortifacants undergo two trans-vaginal probes.
Here’s the relevant language:
“Before giving, selling, dispensing, administering, prescribing, or otherwise providing an erectile dysfunction drug to a man showing symptoms of erectile dysfunction, a physician licensed under IC 25-22.5 shall do the following:
(1) Examine in person the man showing symptoms of erectile dysfunction.
(2) Conduct a prostate examination or oversee a prostate examination by an individual who is licensed or certified in Indiana and whose scope of practice includes the conducting of a prostate examination.
(3) Document the following information on the patient’s medical records:
(A) The size of the patient’s prostate.
(B) Whether the patient is showing symptoms of benign prostate problems.
(C) Whether a benign prostate problem could be contributing to the patient’s erectile dysfunction.
(4) Provide the following information to the man diagnosed with erectile dysfunction:
(A) A copy of the final printed drug label.
(B) The name and telephone number for the physician who prescribed the erectile dysfunction medication and information for follow-up care in the event of an adverse event described in section 2 of this chapter.
(c) A physician licensed under IC 25-22.5 who gives, sells, dispenses, administers, prescribes, or otherwise provides an erectile dysfunction drug to a man shall schedule a follow-up appointment with the man at approximately fourteen (14) days after prescribing the erectile dysfunction drug to:
(1) conduct a physical exam, including an electrocardiogram, to ensure that the man is healthy enough for continued sexual activity; and assess the degree to which the erectile dysfunction drug has aided in temporarily relieving the symptoms of erectile dysfunction.
(d) The physician described in subsection (c) shall make a reasonable effort to ensure that the patient returns for the follow-up appointment described in subsection (c), including recording in the patient’s medical records:
(1) the date and time of the follow-up appointment;
(2) a brief description of the efforts the physician and the physician’s staff took to ensure the patient’s return; and the name of the individual who performed the efforts.
There’s more, but you get the idea.
Gee–I wonder why this eminently reasonable amendment, motivated solely by concern for the health of the male patient, was voted down.